F 0755
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Provide pharmaceutical services to meet the needs of each resident and employ or obtain the services of a
licensed pharmacist.
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
medical record review and staff interview, the facility failed to ensure residents received ordered
medications upon admission. This affected two residents (#15 and #71) of three residents reviewed for
admission medications. The facility census was 70.
Findings include:
1. Review of the medical record for Resident #71 revealed an admission date of 12/28/23 and discharge
date of 01/19/24 with diagnoses including but not limited to metabolic encephalopathy, altered mental
status, acute respiratory failure with hypoxia, fluid overload, congestive heart failure, type two diabetes,
unspecified convulsions, chronic kidney disease stage three, and cognitive communication deficit.
Review of the Minimum Data Set (MDS) assessment dated [DATE] revealed a Brief Interview of Mental
Status (BIMS) score of five which indicated Resident #71 had severely impaired cognition. Resident #71
required extensive assistance for Activities of Daily Living (ADLs).
Review of physician orders dated 12/28/23 revealed divalproex (Depakote - used to treat seizures) 500
milligrams (mg) twice daily, gabapentin (pain medication) 300 mg three times daily, carvedilol (used heart
failure) 25 mg twice daily, and voltaren gel (pain gel) one percent three times daily.
Review of the December Medication Administration Record (MAR) revealed resident did not receive
Depakote 500 mg in the evening, gabapentin 300 mg at 2:00 P.M. and 9:00 P.M., carvedilol 25 mg at 4:00
P.M. and voltaren gel to knee at 5:00 P.M. on 12/28/23 upon admission.
Further review of the medical record revealed no documentation that the medication missed was on hold.
Interview on 01/24/24 at 2:40 P.M. with the Director of Nursing (DON) and Licensed Practical Nurse (LPN)
#622 verified Resident #71 did not receive medications upon admission due to medications not being
available from the pharmacy. LPN #622 stated the Nurse Practitioner (NP) was in the facility that day and
stated it was okay to hold the medication until received by the pharmacy. It was further verified there was no
documentation available regarding the NP approving medications to be held.
2. Review of medical record for Resident #15 revealed an admission date of 11/27/23 with diagnoses
including but not limited to metabolic encephalopathy, altered mental status, Alzheimer's disease, dementia,
epilepsy, and hypertension.
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 2
Event ID:
365849
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
365849
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
01/24/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Ayden Healthcare of Toledo
4293 Monroe St
Toledo, OH 43606
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0755
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Review of the MDS assessment dated [DATE] revealed the resident had severely impaired cognition.
Resident #15 was dependent for ADLs.
Review of physician orders dated 11/27/23 revealed orders for latanoprost ophthalmic solution (eye drops)
0.005 percent (%), lacosamide (used for seizures) 10 mg/milliliters (ml): 10 ml every 12 hours,
levetiracetam oral solution (antiepileptic) 100 mg/ml: 15 ml at bedtime.
Review of the MAR for November revealed the resident did not receive latanoprost ophthalmic solution,
lacosamide 10 ml, and levetiracetam 15 ml at bedtime on 11/27/23.
Interview on 01/24/24 at 2:40 P.M. with the Director of Nursing (DON) verified that Resident #15 did not
receive medications due to waiting on the pharmacy to deliver.
Review of policy titled, Administering Medications, revised December 2012 revealed medications must be
administered in accordance with the orders, including any required time frame.
This deficiency represents non-compliance investigated under Complaint Number OH00149677.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
365849
If continuation sheet
Page 2 of 2